217480 — SD Biotechnologies Co Cashflow Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro Cap

Annual cashflow statement for SD Biotechnologies Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS/A	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-22,021	-9,765	-45,149	—	—
Depreciation
Amortisation
Non-Cash Items	24,061	-1,224	15,776	—	—
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	2,328	2,988	8,122	-21,423	-6,300
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	6,738	-4,580	-17,311	-15,367	-3,115
Capital Expenditures	-12,255	-4,286	-16,323	-24,323	-1,049
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	4,722	-5,427	14,359	22,273	6,610
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-7,533	-9,713	-1,964	-2,051	5,561
Financing Cash Flow Items	200	—	-419	—	—
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	627	16,753	19,952	10,226	9,389
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	99.9	2,523	2,479	-7,161	12,233